Evidence map›Paper›PMID 26788032›Full record

ArticleDose-response : a publication of International Hormesis Society

Low-Dose Radiation Induces Cell Proliferation in Human Embryonic Lung Fibroblasts but not in Lung Cancer Cells: Importance of ERK1/2 and AKT Signaling Pathways.

Xinyue Liang, Junlian Gu, Dehai Yu, Guanjun Wang, Lei Zhou, Xiaoying Zhang, Yuguang Zhao, Xiao Chen, Shirong Zheng, Qiang Liu and 3 more

Open access · goldAbstract read
In one paragraph

Article in Dose-response : a publication of International Hormesis Society. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
5.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 52 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Low-Dose Non-Targeted Effects and Mitochondrial Control.International journal of molecular sciences · 2023
    Review
  7. Human enteroids as a tool to study conventional and ultra-high dose rate radiation.Integrative biology : quantitative biosciences from nano to macro · 2023
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. COVID-19 and low-dose radiation therapy.Radiation medicine and protection · 2021
    Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

Xinyue LiangCancer Center, the First Hospital of Jilin University, Changchun, China; Department of Pediatrics, Kosair Children's Hospital Research Institute, University of Louisville, Louisville, KY, USA.
Junlian GuDepartment of Pediatrics, Kosair Children's Hospital Research Institute, University of Louisville, Louisville, KY, USA.
Dehai YuCancer Center, the First Hospital of Jilin University, Changchun, China.
Guanjun WangCancer Center, the First Hospital of Jilin University, Changchun, China.
Lei ZhouCancer Center, the First Hospital of Jilin University, Changchun, China.
Xiaoying ZhangCancer Center, the First Hospital of Jilin University, Changchun, China.
Yuguang ZhaoCancer Center, the First Hospital of Jilin University, Changchun, China.
Xiao ChenCancer Center, the First Hospital of Jilin University, Changchun, China.
Shirong ZhengDepartment of Pediatrics, Kosair Children's Hospital Research Institute, University of Louisville, Louisville, KY, USA.
Qiang LiuTianjin Key Lab of Radiation and Molecular Nuclear Medicine, Institute of Radiation Medicine, Chinese Academy of Medical Science and Peking Union Medical College, Tianjin, China.
Lu CaiDepartment of Pediatrics, Kosair Children's Hospital Research Institute, University of Louisville, Louisville, KY, USA.
Jiuwei CuiCancer Center, the First Hospital of Jilin University, Changchun, China.
Wei LiCancer Center, the First Hospital of Jilin University, Changchun, China.
First Hospital of Jilin University · CNJilin University · CNKosair Children's Hospital · USUniversity of Louisville · USChinese Academy of Medical Sciences & Peking Union Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hormesis and adaptive responses are 2 important biological effects of low-dose ionizing radiation (LDR). In normal tissue, LDR induces hormesis as evinced by increased cell proliferation; however, whether LDR also increases tumor cell proliferation needs to be investigated. In this study, cell proliferation was assayed by total cell numbers and the Cell Counting Kit 8 assay. Mitogen-activated protein kinases (MAPK)/extracellular signal-regulated kinase (ERK) and phosphatidylinositol 3' -kinase(PI3K)-Akt (PI3K/AKT) phosphorylation were determined by Western blot analysis. Human embryonic lung fibroblast 2BS and lung cancer NCI-H446 cell lines were irradiated with LDR at different doses (20-100 mGy). In response to 20 to 75 mGy X-rays, cell proliferation was significantly increased in 2BS but not in NCI-H446 cells. In 2BS cells, LDR at 20 to 75 mGy also stimulated phosphorylation of MAPK/ERK pathway proteins including ERK, MEK, and Raf and of the PI3K/AKT pathway protein AKT. To test whether ERK1/2 and AKT pathway activation was involved in the stimulation of cell proliferation in 2BS cells, the MAPK/ERK and PI3K/AKT pathways were inhibited using their specific inhibitors, U0126 and LY294002. U0126 decreased the phosphorylation of ERK1/2, and LY294002 decreased the phosphorylation of AKT; each could significantly inhibit LDR-induced 2BS cell proliferation. However, LDR did not stimulate these kinases, and kinase inhibitors also did not affect cell proliferation in the NCI-H446 cells. These results suggest that LDR stimulates cell proliferation via the activation of both MAPK/ERK and PI3K/AKT signaling pathways in 2BS but not in NCI-H446 cells. This finding implies the potential for applying LDR to protect normal tissues from radiotherapy without diminishing the efficacy of tumor therapy.

Indexed as

cell proliferationhormesisionizing radiationlow dose

Identifiers

PMID26788032
PMCPMC4710120
OpenAlexW2309182611

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.